ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

POLB Poolbeg Pharma Plc

5.15
-0.45 (-8.04%)
10 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Poolbeg Pharma Plc LSE:POLB London Ordinary Share GB00BKPG7Z60 ORD 0.02P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.45 -8.04% 5.15 5.00 5.30 5.75 5.15 5.60 3,897,651 16:09:48
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 0 -3.93M -0.0079 -6.52 28M
Poolbeg Pharma Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker POLB. The last closing price for Poolbeg Pharma was 5.60p. Over the last year, Poolbeg Pharma shares have traded in a share price range of 3.60p to 15.70p.

Poolbeg Pharma currently has 500,000,000 shares in issue. The market capitalisation of Poolbeg Pharma is £28 million. Poolbeg Pharma has a price to earnings ratio (PE ratio) of -6.52.

Poolbeg Pharma Share Discussion Threads

Showing 3751 to 3772 of 3975 messages
Chat Pages: 159  158  157  156  155  154  153  152  151  150  149  148  Older
DateSubjectAuthorDiscuss
09/12/2024
08:33
Phone CF to confirm that it works and would not just potentially work as previously reported .Would anyone here make that call ?
baldrick1
09/12/2024
08:10
We've known this since November 6th..
chica1
09/12/2024
07:52
Thanks my apologies
peterrr3
09/12/2024
07:28
It’s a brand new trial.
troutisout
09/12/2024
07:25
Good morning,I hope all is well and please see link to RNS Reach issued by Poolbeg this morning: https://www.londonstockexchange.com/news-article/POLB/ poolbeg=presents-polb-001-data-at-66th-ash-meeting/16801054We are delighted to share key insights from our poster presented over the weekend at the prestigious 66th American Society of Hematology (ASH) annual meeting, the world's leading conference on hematological malignancies (blood cancers).The poster detailed data from the POLB 001 pre-clinical study which completed earlier this year. The study found that all doses of POLB 001 significantly reduced clinically observed Cytokine Release Syndrome (CRS) scores and demonstrated superior cytokine inhibition compared to Adalimumab, an anti-TNF antibody which is a gold standard potent inhibitor of CRS in humanized tumour-bearing mouse models.The results of this animal study reinforce the use case forPOLB 001 in the prevention and treatment of cancer immunotherapy-induced CRS. The previous successful LPS trial in healthy human volunteers also provides ratification.Addressing cancer immunotherapy-induced CRS holds the potential to greatly impact the treatment of hematological malignancies - enhancing safety and reaching more patients.We are delighted to have shared these significant insights with potential partners and experts in the field.Don't hesitate to contact me should you have any questions.Kind regards,Cathal Frielhttps://www.londonstockexchange.com/news-article/POLB/poolbeg-presents-polb-001-data-at-66th-ash-meeting/16801054
burtond1
09/12/2024
07:10
RNS presents years old trials results as news. Worth a go I guess.
peterrr3
06/12/2024
15:13
I'm not on telegram, and what do they know that's being kept secret from us ? ;))
baldrick1
06/12/2024
15:04
Or is this the telegram secret Santa?
peterrr3
06/12/2024
15:02
Seems to indicate you have joined them Baldy
peterrr3
06/12/2024
14:38
I do think CF and Co. Is giving the discreet nods up to the century buyers ;)))
baldrick1
06/12/2024
12:52
Let's hope we can join them ;))
baldrick1
06/12/2024
12:29
They are in a blackout for the Xmas party, so they can't.
peterrr3
06/12/2024
09:12
Are there anymore directors buying this?
baldrick1
28/11/2024
09:03
And I thought it was Xmas party season.One last roll of the dice before the festivities. Cheap Ryan Air flights, maybe you could go and report back Baldrick?https://www.linkedin.com/posts/poolbeg-pharma_polb-genecelltherapy-celltherapy-activity-7267807605450801152-RfZY?utm_source=share&utm_medium=member_ios
peterrr3
26/11/2024
13:47
I may take a punt when it drops to 4-5p before Xmas.
baldrick1
26/11/2024
10:23
Hello Pogue.l did check my mail and fud not receive anything. I normally receive a mail when a webinar is scheduled but did not receive anything.
spuddymadrid
26/11/2024
09:51
Hello Pogue. Hope you are well. Do you know if there is a link to the interview. Regards
spuddymadrid
26/11/2024
09:43
That's what second hand car salesmen do.
owenski
26/11/2024
09:39
That was most definitely not what he said last year and throughout 2024 though, it feels like he keeps us hanging on false promises!
discojames
26/11/2024
09:08
discojames
What I liked about the presention was that he restated there is zero need for a fundraise with £10 million in the bank and all current trails are funded outside that amount proving some more negative posters wrong in thier theories and confirming what I said.
Re 1 to 2 years he was refering to the prospects of the company over the next one or two years not POLB001 or the pipeline drugs behind it. They will come when they come as he said.

pogue
26/11/2024
08:46
Hello Discojames. What interview ? Do you have a link ?
Regards

spuddymadrid
26/11/2024
08:35
Good old CF, typical second hand car salesman, promising all sorts with the car purchase but it's delivered with no floor mats and no radio, wheel trims missing too. lol
owenski
Chat Pages: 159  158  157  156  155  154  153  152  151  150  149  148  Older

Your Recent History

Delayed Upgrade Clock